The researchers used spatial proteomics to analyze skin samples from patients with toxic epidermal necrolysis. This ...

Pfizer's PATINA trial highlights IBRANCE's potential in HR+/HER2+ metastatic breast cancer, improving outcomes with a ...

This technology is also likely to be applicable to targeted therapy of epidermal disorders and skin cancer. Further development is in progress in anticipation of clinical vaccination trials.

Although the intramuscular route is commonly used for administering human vaccines, subcutaneous, intraperitoneal and intramuscular routes are often used interchangeably for immunizing ...

Pfizer (PFE) and Alliance Foundation Trials announced results from the Phase 3 PATINA trial demonstrating that the addition of Ibrance to ...

According to the classical understanding of plant gas exchange, the uncontrolled loss of water from plant aerial organs is restricted by epidermis that is covered by a hydrophobic layer called cuticle ...

Tissue adhesive had a lower rate of surgical site infections when compared with suture for epidermal closure in dermatologic surgery.

Scientists are making waves with a novel therapy for metastatic colorectal cancer (mCRC) that combines two powerful antibodies—one targeting epidermal growth factor receptor (EGFR), the other ...

On Wednesday November 20, on the occasion of the Making Cosmetics trade show in Milan, SILAB's natural anti-aging active ...

Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE®) to current standard-of-care ...